CXCR4 and non-Hodgkin lymphoma: When we specifically evaluated CD20+ and CXCR4 high-expressing B cells by unsupervised clustering, we identified elevated levels of CD20+CXCR4hiAICDA+ B cells in HIV+ pre-NHL (cART-naïve) compared to HIV+ samples (MC23) (Figure 5D).